Fintel reports that on September 29, 2025, Chardan Capital initiated coverage of Immunic (NasdaqGS:IMUX) with a Buy recommendation. Analyst Price Forecast Suggests 725.47% Upside As of September 13, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback